Triple
T18923652
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | World Health Professions Alliance |
E462923
|
entity |
| Predicate | hasMemberOrganization |
P12024
|
FINISHED |
| Object | International Pharmaceutical Federation |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: International Pharmaceutical Federation | Statement: [World Health Professions Alliance, hasMemberOrganization, International Pharmaceutical Federation]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: International Pharmaceutical Federation Context triple: [World Health Professions Alliance, hasMemberOrganization, International Pharmaceutical Federation]
-
A.
European Federation of Pharmaceutical Industries and Associations
The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association representing the research-based pharmaceutical industry in Europe, advocating for policies that support innovation, patient access to medicines, and a competitive life sciences sector.
-
B.
Japan Pharmaceutical Manufacturers Association
The Japan Pharmaceutical Manufacturers Association is a major industry organization representing research-based pharmaceutical companies in Japan and contributing to international regulatory harmonization and policy development.
-
C.
General Pharmaceutical Council
The General Pharmaceutical Council is the independent regulator for pharmacists, pharmacy technicians, and pharmacy premises in Great Britain, setting standards for education, training, and professional practice.
-
D.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
-
E.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: International Pharmaceutical Federation Target entity description: The International Pharmaceutical Federation is a global federation representing pharmacists and pharmaceutical scientists, working to advance pharmacy practice, science, and education worldwide.
-
A.
European Federation of Pharmaceutical Industries and Associations
The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association representing the research-based pharmaceutical industry in Europe, advocating for policies that support innovation, patient access to medicines, and a competitive life sciences sector.
-
B.
Japan Pharmaceutical Manufacturers Association
The Japan Pharmaceutical Manufacturers Association is a major industry organization representing research-based pharmaceutical companies in Japan and contributing to international regulatory harmonization and policy development.
-
C.
General Pharmaceutical Council
The General Pharmaceutical Council is the independent regulator for pharmacists, pharmacy technicians, and pharmacy premises in Great Britain, setting standards for education, training, and professional practice.
-
D.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
-
E.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8dcfdbbb881909964fa5a75bd0b48 |
completed | April 10, 2026, 11:20 a.m. |
| NER | Named-entity recognition | batch_69e5c9b549448190850d7eed4de7872b |
completed | April 20, 2026, 6:37 a.m. |
Created at: April 10, 2026, 11:59 a.m.